{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:23:54Z","timestamp":1791134634849,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.neuropharm.2007.01.005","type":"journal-article","created":{"date-parts":[[2007,1,21]],"date-time":"2007-01-21T12:08:20Z","timestamp":1169381300000},"page":"1336-1341","source":"Crossref","is-referenced-by-count":39,"title":["The mu opioid receptor is involved in buprenorphine-induced locomotor stimulation and conditioned place preference"],"prefix":"10.1016","volume":"52","author":[{"given":"Paul","family":"Marquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramkumarie","family":"Baliram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte L.","family":"Kieffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kabirullah","family":"Lutfy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2007.01.005_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002130000569","article-title":"Conditioned place preference: what does it add to our preclinical understanding of drug reward?","volume":"153","author":"Bardo","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2007.01.005_bib2","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0196-9781(00)00252-7","article-title":"Agonistic effects of the opioid buprenorphine on the nociceptin\/OFQ receptor","volume":"21","author":"Bloms-Funke","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2007.01.005_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-2999(00)00590-2","article-title":"Effect of nociceptin\/orphanin FQ on the rewarding properties of morphine","volume":"404","author":"Ciccocioppo","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl.","key":"10.1016\/j.neuropharm.2007.01.005_bib4","first-page":"3","article-title":"Buprenorphine: new pharmacological aspects","author":"Cowan","year":"2003","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1476-5381.1977.tb07533.x","article-title":"The animal pharmacology of buprenorphine, an oripavine analgesic agent","volume":"60","author":"Cowan","year":"1977","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1476-5381.1977.tb07532.x","article-title":"Agonist and antagonist properties of buprenorphine, a new antinociceptive agent","volume":"60","author":"Cowan","year":"1977","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib7","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib8","first-page":"1067","article-title":"Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats","volume":"244","author":"Di Chiara","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2007.01.005_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuropharm.2004.06.032","article-title":"Dopamine and drug addiction: the nucleus accumbens shell connection","volume":"47","author":"Di Chiara","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2007.01.005_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-2999(99)00904-8","article-title":"Opioid activity profiles indicate similarities between the nociceptin\/orphanin FQ and opioid receptors","volume":"389","author":"Hawkinson","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib11","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nature04172","article-title":"Morphine reward in dopamine-deficient mice","volume":"438","author":"Hnasko","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2007.01.005_bib12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-3565(24)29586-0","article-title":"Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist","volume":"297","author":"Huang","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib13","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/sj.npp.1300463","article-title":"Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice","volume":"29","author":"Ide","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2007.01.005_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1254\/jjp.40.95","article-title":"Agonist and antagonist actions of buprenorphine on three types of opioid receptor in isolated preparations","volume":"40","author":"Kajiwara","year":"1986","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib15","doi-asserted-by":"crossref","first-page":"L285","DOI":"10.1016\/0024-3205(95)00078-X","article-title":"Buprenorphine exerts its antinociceptive activity via mu 1-opioid receptors","volume":"56","author":"Kamei","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/S0024-3205(97)00170-7","article-title":"Antinociceptive effect of buprenorphine in mu1-opioid receptor deficient CXBK mice","volume":"60","author":"Kamei","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/science.278.5335.52","article-title":"Drug abuse: hedonic homeostatic dysregulation","volume":"278","author":"Koob","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2007.01.005_bib18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1176\/jnp.9.3.482","article-title":"The neurobiology of drug addiction","volume":"9","author":"Koob","year":"1997","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib19","first-page":"395","article-title":"Buprenorphine: a unique drug with complex pharmacology","volume":"2","author":"Lutfy","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2007.01.005_bib20","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1523\/JNEUROSCI.23-32-10331.2003","article-title":"Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors","volume":"23","author":"Lutfy","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1037\/0735-7044.120.1.10","article-title":"Differential involvement of enkephalins in analgesic tolerance, locomotor sensitization, and conditioned place preference induced by morphine","volume":"120","author":"Marquez","year":"2006","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib22","first-page":"517","article-title":"The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib23","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/383819a0","article-title":"Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene","volume":"383","author":"Matthes","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2007.01.005_bib24","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/377532a0","article-title":"Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor","volume":"377","author":"Meunier","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2007.01.005_bib25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0031-6997(24)01502-3","article-title":"The molecular and behavioral pharmacology of the orphanin FQ\/nociceptin peptide and receptor family","volume":"53","author":"Mogil","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0006-8993(99)01425-0","article-title":"Orphanin FQ\/nociceptin blocks acquisition of morphine place preference","volume":"832","author":"Murphy","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib27","first-page":"518","article-title":"Kappa antagonist effects of buprenorphine in the rat drug-discrimination procedure","volume":"95","author":"Negus","year":"1989","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00008877-200211000-00005","article-title":"Delta opioid antagonist effects of buprenorphine in rhesus monkeys","volume":"13","author":"Negus","year":"2002","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/scientificamerican0304-78","article-title":"The addicted brain","volume":"290","author":"Nestler","year":"2004","journal-title":"Sci. Am."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib30","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/0269881105053308","article-title":"The place of partial agonism in psychiatry: recent developments","volume":"19","author":"Ohlsen","year":"2005","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib31","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.270.5237.792","article-title":"Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor","volume":"270","author":"Reinscheid","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2007.01.005_bib32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1527-3458.2002.tb00235.x","article-title":"Buprenorphine: an analgesic with an expanding role in the treatment of opioid addiction","volume":"8","author":"Robinson","year":"2002","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.neuropharm.2007.01.005_bib33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0165-0173(93)90013-P","article-title":"The neural basis of drug craving: an incentive-sensitization theory of addiction","volume":"18","author":"Robinson","year":"1993","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2007.01.005_bib34","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1046\/j.1360-0443.95.8s2.19.x","article-title":"The psychology and neurobiology of addiction: an incentive-sensitization view","volume":"95","author":"Robinson","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.neuropharm.2007.01.005_bib35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0091-3057(94)90484-7","article-title":"Dissociation of buprenorphine-induced locomotor sensitization and conditioned place preference in rats","volume":"49","author":"Rowlett","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib36","first-page":"157","article-title":"Buprenorphine: differential interaction with opiate receptor subtypes in vivo","volume":"223","author":"Sadee","year":"1982","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00213-003-1388-z","article-title":"Interactions between opioids and cocaine on locomotor activity in rats: influence of an opioid's relative efficacy at the mu receptor","volume":"167","author":"Smith","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2007.01.005_bib38","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.pbb.2006.05.013","article-title":"The effects of long-term chronic buprenorphine treatment on the locomotor and nucleus accumbens dopamine response to acute heroin and cocaine in rats","volume":"84","author":"Sorge","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib39","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/sj.npp.1300712","article-title":"Rats maintained chronically on buprenorphine show reduced heroin and cocaine seeking in tests of extinction and drug-induced reinstatement","volume":"30","author":"Sorge","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2007.01.005_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-002-1003-8","article-title":"Behavioral pharmacology of buprenorphine, with a focus on preclinical models of reward and addiction","volume":"161","author":"Tzschentke","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2007.01.005_bib41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00213-003-1626-4","article-title":"Reassessment of buprenorphine in conditioned place preference: temporal and pharmacological considerations","volume":"172","author":"Tzschentke","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2007.01.005_bib42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0163-7258(87)90108-2","article-title":"The role of reward pathways in the development of drug dependence","volume":"35","author":"Wise","year":"1987","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2007.01.005_bib43","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/mol.56.2.334","article-title":"Agonistic effect of buprenorphine in a nociceptin\/OFQ receptor-triggered reporter gene assay","volume":"56","author":"Wnendt","year":"1999","journal-title":"Mol. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807000081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807000081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T03:10:36Z","timestamp":1736737836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390807000081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0028390807000081"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2007.01.005","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}